Home/Pipeline/Influenza Vaccine

Influenza Vaccine

Seasonal Influenza Prevention

ApprovedCommercial

Key Facts

Indication

Seasonal Influenza Prevention

Phase

Approved

Status

Commercial

Company

Sinopharm

About Sinopharm

Sinopharm is a Fortune Global 500 company and China's largest pharmaceutical conglomerate, encompassing drug distribution, manufacturing, research and development, and healthcare services. The company gained global recognition for developing one of China's first approved COVID-19 vaccines (BBIBP-CorV) and has established itself as a key player in international vaccine diplomacy. With operations spanning across multiple therapeutic areas and a vast distribution network, Sinopharm serves as a critical component of China's healthcare infrastructure.

View full company profile

Therapeutic Areas

Vaccines Infectious Diseases Traditional Chinese Medicine Generic Drugs Biologics

Other Seasonal Influenza Prevention Drugs

Drug	Company	Phase	Status
Seasonal Influenza Vaccine (Split Virion)	Hualan Biological Engineering	Approved	Commercial
Quadrivalent Influenza Vaccine (Split Virion)	Hualan Biological Engineering	Approved	Commercial